Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Secondary Prophylaxis With Oral Vancomycin for Clostridium Difficile Recurrence: A Randomized Control Study

NCT03200093 is registered in ClinicalTrials.gov with Rochester General Hospital as lead sponsor.

NCT NCT03200093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03200093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Secondary Prophylaxis With Oral Vancomycin for Clostridium Difficile Recurrence: A Randomized Control Study
Lead sponsor
Rochester General Hospital
Phase
Phase 4
Overall status
Terminated
Start date
June 8, 2017
Completion date
April 22, 2021
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile infection